Kevin B. Jones
( out of 122 reviews )

Kevin B. Jones, MD

Languages spoken: Spanish, English

Clinical Locations

Primary Location

Primary Children's Hospital

Pediatric Orthopaedics
100 N Mario Capecchi Drive
Salt Lake City , UT 84113
801-662-5600
Get Directions

Huntsman Cancer Institute - Cancer Hospital South

Clinic 3A, Sarcoma
1950 Circle of Hope
Salt Lake City , UT 84112
801-585-7180
Get Directions

Kevin B. Jones, MD

Leader, Huntsman Cancer Institute Sarcoma Disease Center

Division Chief, Sarcoma, Department of Orthopaedics

Professor, Department of Orthopaedics and

Adjunct Professor of Oncological Sciences

As an orthopaedic surgeon specialized in the care of pediatric and adult patients with sarcoma, I see first-hand the limitations and frank failures of the currently available treatment options. Not only do we fail to cure far too many young patients with sarcomas, but the long-term effects of our treatments create other major challenges to the health of the survivors in the long term.

With protected time for basic investigation, I dedicate my entire laboratory to the study of pediatric and young adult fusion oncogene-associated sarcomas. In efforts always angling toward improved targeted therapies, we use mouse genetic models of sarcomagenesis to dissect pathways of importance to initiation and progression of tumors. This work utilizes conditional activation of translocation-associated fusion oncogenes as well as manipulation of additional modifying genes directed toward improved understanding of the conditions that promote or inhibit sarcomagenesis. This work has led to generous experience with comparative genomics and epigenomics.

The simple genetic changes that drive translocation-associated sarcomas make a strong argument for cancer being defined as a transcriptional state for cells, rather than a state of accumulated mutations or genetic losses and gains. The study of the epigenetic determinants of this transcriptional state in cells that harbor very few genetic code alterations has already revealed important knowledge that pertains to more complex genome cancer types as well as to transcriptional biology more generally.

I also believe firmly in the synergy possible in collaborative team science. Such efforts are required for progress toward improved treatments for rare malignancies that can never be studied with optimal efficacy in a silo. With such collaborative work as direct goal, I have participated in and assembled teams to work on pediatric sarcomas both within my institution and internationally.

Specialties

Board Certification

American Board of Orthopaedic Surgery

Patient Rating

4.9 /5
( out of 122 reviews )

The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

The scale on which responses are measured is 1 to 5 with 5 being the best score.

Patient Comments

Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

HUNTSMAN CANCER CENTER

Excellent provider. Very caring and accessible to patients, willing to take the time to make sure they are comfortable with their surgeries and focused on their longterm quality of life.

HUNTSMAN CANCER CENTER

Great bedside manner and good listener.

HUNTSMAN CANCER CENTER

The discussion we had about my journey made me feel that I am on the right track to resolve my condition.

HUNTSMAN CANCER CENTER

More than any person, I have Dr. Jones to thank for saving my life and my arm. He is as compassionate and caring as he is competent. I cannot sing his praises enough.

HUNTSMAN CANCER CENTER

Highly professional and caring

HUNTSMAN CANCER CENTER

We thought he a great Dr very respectful and kirtes

HUNTSMAN CANCER CENTER

Extremely professional, knowledgeable and personable

PRIMARY CHILDREN'S MEDICAL CENTER

Dr Jones is amazing. We felt extremely reassured by his competency and knowledge. He was also so caring about our son, making sure that we had every resource to resolve the issue. Impeccable bedside manner. You can tell he genuinely cares for his patients and it shows in his work and each interaction.

HUNTSMAN CANCER CENTER

I greatly respect and admire Dr. Jones and his leadership as it pertains to my overall cancer treatment. He has been understanding and supportive as I have negotiated a very difficult time in my life. His personal team and the others that he has brought in to help us navigate my cancer journey have been the most professional, kind and caring people I have ever met.

Kevin B. Jones, MD

Leader, Huntsman Cancer Institute Sarcoma Disease Center

Division Chief, Sarcoma, Department of Orthopaedics

Professor, Department of Orthopaedics and

Adjunct Professor of Oncological Sciences

As an orthopaedic surgeon specialized in the care of pediatric and adult patients with sarcoma, I see first-hand the limitations and frank failures of the currently available treatment options. Not only do we fail to cure far too many young patients with sarcomas, but the long-term effects of our treatments create other major challenges to the health of the survivors in the long term.

With protected time for basic investigation, I dedicate my entire laboratory to the study of pediatric and young adult fusion oncogene-associated sarcomas. In efforts always angling toward improved targeted therapies, we use mouse genetic models of sarcomagenesis to dissect pathways of importance to initiation and progression of tumors. This work utilizes conditional activation of translocation-associated fusion oncogenes as well as manipulation of additional modifying genes directed toward improved understanding of the conditions that promote or inhibit sarcomagenesis. This work has led to generous experience with comparative genomics and epigenomics.

The simple genetic changes that drive translocation-associated sarcomas make a strong argument for cancer being defined as a transcriptional state for cells, rather than a state of accumulated mutations or genetic losses and gains. The study of the epigenetic determinants of this transcriptional state in cells that harbor very few genetic code alterations has already revealed important knowledge that pertains to more complex genome cancer types as well as to transcriptional biology more generally.

I also believe firmly in the synergy possible in collaborative team science. Such efforts are required for progress toward improved treatments for rare malignancies that can never be studied with optimal efficacy in a silo. With such collaborative work as direct goal, I have participated in and assembled teams to work on pediatric sarcomas both within my institution and internationally.

Board Certification and Academic Information

Academic Departments Orthopaedics -Professor
Oncological Sciences -Adjunct Professor
Board Certification
American Board of Orthopaedic Surgery

Education history

Undergraduate English and American Literature and Language - Harvard University A.B.
Professional Medical Medicine - Johns Hopkins University M.D.
Residency Orthopaedic Surgery - University of Iowa Hospitals and Clinics Resident
Fellowship Musculoskeletal Oncology - Mount Sinai Hospital Fellow
Other Training Mentored Scientific Training-Mouse Genetic Modeling of Sarcoma - Mario Capecchi Laboratory, University of Utah

Selected Publications

Journal Article

  1. Jones KB, Schiffman JD, Kohlmann W, Randall RL, Lessnick SL, Cannon-Albright L (2011). Complex genotype sarcomas display familial inheritance independent of known cancer predisposition syndromes. Cancer epidemiology, biomarkers & prevention, 20(5), 751-7.
  2. Stacchiotti S, Frezza AM, Blay JY, Baldini EH, Bonvalot S, Bovée JVMG, Callegaro D, Casali PG, Chiang RC, Demetri GD, Demicco EG, Desai J, Eriksson M, Gelderblom H, George S, Gounder MM, Gronchi A, Gupta A, Haas RL, Hayes-Jardon A, Hohenberger P, Jones KB, Jones RL, Kasper B, Kawai A, Kirsch DG, Kleinerman ES, Le Cesne A, Lim J, Chirlaque López MD, Maestro R, Marcos-Gragera R, Martin Broto J, Matsuda T, Mir O, Patel SR, Raut CP, Razak ARA, Reed DR, Rutkowski P, Sanfilippo RG, Sbaraglia M, Schaefer IM, Strauss DC, Sundby Hall K, Tap WD, Thomas DM, van der Graaf WTA, van Houdt WJ, Visser O, von Mehren M, Wagner AJ, Wilky BA, Won YJ, Fletcher CDM, Dei Tos AP, Trama (2021). Ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities. Cancer, 127(16), 2934-2942.
  3. Jones KB, Salah Z, Del Mare S, Galasso M, Gaudio E, Nuovo GJ, Lovat F, LeBlanc K, Palatini J, Randall RL, Volinia S, Stein GS, Croce CM, Lian JB, Ageilan R (2012). miRNA signatures associate with pathogenesis and progression of osteosarcoma. Cancer research, 72(7), 1865-77.
  4. Jones KB, Salah Z, Del Mare S, Galasso M, Gaudio E, Nuovo GJ, Lovat F, LeBlanc K, Palatini J, Randall RL, Volinia S, Stein GS, Croce CM, Lian JB, Aqeilan R (2012). miRNA signatures associate with pathogenesis and progression of osteosarcoma. Cancer research, 72(7), 1865-77.
  5. Lambert SL, Jones K (2020). SKP2 My Lou, My Darling. Cancer research, 80(12), 2437-2438.
  6. Monument MJ, Bernthal NM, Bowles AJ, Jones KB, Randall R (2015). What are the 5-year survivorship outcomes of compressive endoprosthetic osseointegration fixation of the femur?. Clinical orthopaedics and related research, 473(3), 883-90.
  7. Groundland J, Brown JM, Monument M, Bernthal N, Jones KB, Randall R (2021). What Are the Long-term Surgical Outcomes of Compressive Endoprosthetic Osseointegration of the Femur with a Minimum 10-year Follow-up Period?. Clinical orthopaedics and related research, 480, 539-548.
  8. Jones KB, Ferguson PC, Lam B, Biau DJ, Hopyan S, Deheshi B, Griffin AM, White LM, Wunder J (2012). Effects of neoadjuvant chemotherapy on image-directed planning of surgical resection for distal femoral osteosarcoma. The Journal of bone and joint surgery. American volume, 94(15), 1399-405.
  9. Jones K (2007). Reliability of histopathologic and radiologic grading of cartilaginous neoplasms in long bones [Skeletal Lesion Interobserver Correlation among Expert Diagnosticians (SLICED) Study Group ]. The Journal of bone and joint surgery. American volume, 89(10), 2113-2123.
  10. Barrott JJ, Illum BE, Jin H, Hedberg ML, Wang Y, Grossmann A, Haldar M, Capecchi MR, Jones K (2018). Paracrine osteoprotegerin and beta-catenin stabilization support synovial sarcomagenesis in periosteal cells. The Journal of clinical investigation, 128(1), 207-218.
  11. Panza E, Ozenberger BB, Straessler KM, Barrott JJ, Li L, Wang Y, Xie M, Boulet A, Titen SW, Mason CC, Lazar AJ, Ding L, Capecchi MR, Jones K (2021). The clear cell sarcoma functional genomic landscape. The Journal of clinical investigation, 131(15),
  12. Barrott JJ, Kafchinski LA, Jin H, Potter JW, Kannan SD, Kennedy R, Mosbruger T, Wang WL, Tsai JW, Araujo DM, Liu T, Capecchi MR, Lazar AJ, Jones K (2016). Modeling synovial sarcoma metastasis in the mouse: PI3'-lipid signaling and inflammation. The Journal of experimental medicine, 213(13), 2989-3005.
  13. Jones KB, Datar M, Ravichandran S, Jin H, Jurrus E, Whitaker R, Capecchi M (2013). Toward an understanding of the short bone phenotype associated with multiple osteochondromas. Journal of orthopaedic research, 31(4), 651-7.
  14. de Andrea CE, Zhu JF, Jin H, Bovee JV, Jones K (2015). Cell cycle deregulation and mosaic loss of Ext1 drive peripheral chondrosarcomagenesis in the mouse and reveal an intrinsic cilia deficiency. The Journal of pathology, 236(2), 210-8.
  15. Kannan S, Lock I, Ozenberger BB, Jones K (2021). Genetic drivers and cells of origin in sarcomagenesis. The Journal of pathology, 254(4), 474-493.
  16. Groundland J, Brown J, Jones K, Randall R (2021). Is osseous reattachment of the greater trochanter necessary compared to soft-tissue-only abductor repair in proximal femoral megaprosthesis reconstruction?. Journal of surgical oncology, 124(1), 115-123.
  17. Jones KB, Su L, Jin H, Lenz C, Randall RL, Underhill TM, Nielsen TO, Sharma S, Capecchi M (2013). SS18-SSX2 and the mitochondrial apoptosis pathway in mouse and human synovial sarcomas. Oncogene, 32(18), 2365-71, 2375.e1-5.
  18. Quist T, Jin H, Zhu JF, Smith-Fry K, Capecchi MR, Jones K (2015). The impact of osteoblastic differentiation on osteosarcomagenesis in the mouse. Oncogene, 34(32), 4278-84.
  19. Jones KB, Barrott JJ, Xie M, Haldar M, Jin H, Zhu JF, Monument MJ, Mosbruger TL, Langer EM, Randall RL, Wilson RK, Cairns BR, Ding L, Capecchi M (2016). The impact of chromosomal translocation locus and fusion oncogene coding sequence in synovial sarcomagenesis. Oncogene, 35(38), 5021-32.
  20. Jones KB, Piombo V, Searby C, Kurriger G, Yang B, Grabellus F, Roughley PJ, Morcuende JA, Buckwalter JA, Capecchi MR, Vortkamp A, Sheffield V (2010). A mouse model of osteochondromagenesis from clonal inactivation of Ext1 in chondrocytes. Proceedings of the National Academy of Sciences of the United States of America, 107(5), 2054-9.
  21. Jones KB, Buckwalter JA, Frassica FJ, McCarthy E (2006). Intracortical chondroma: a report of two cases. Skeletal radiology, 35(5), 298-301.
  22. Israelsen RB, Illum BE, Crabtree S, Randall RL, Jones K (2011). Extremity sarcoma surgery in younger children: ten years of patients ten years and under. The Iowa orthopaedic journal, 31, 145-53.
  23. Tashjian RZ, Kim SK, Roche MD, Jones KB, Teerlink C (2021). Genetic variants associated with rotator cuff tearing utilizing multiple population-based genetic resources. Journal of shoulder and elbow surgery, 30(3), 520-531.
  24. Kim SK, Nguyen C, Jones KB, Tashjian R (2021). A genome-wide association study for shoulder impingement and rotator cuff disease. Journal of shoulder and elbow surgery, 30(9), 2134-2145.
  25. Nacev BA, Jones KB, Intlekofer AM, Yu JSE, Allis CD, Tap WD, Ladanyi M, Nielsen T (2020). The epigenomics of sarcoma. Nature reviews. Cancer, 20(10), 608-623.
  26. Su L, Sampaio AV, Jones KB, Pacheco M, Goytain A, Lin S, Poulin N, Yi L, Rossi FM, Kast J, Capecchi MR, Underhill TM, Nielsen T (2012). Deconstruction of the SS18-SSX fusion oncoprotein complex: insights into disease etiology and therapeutics. Cancer cell, 21(3), 333-47.
  27. Straessler KM, Jones KB, Hu H, Jin H, van de Rijn M, Capecchi M (2013). Modeling clear cell sarcomagenesis in the mouse: cell of origin differentiation state impacts tumor characteristics. Cancer cell, 23(2), 215-27.
  28. Goodwin ML, Jin H, Straessler K, Smith-Fry K, Zhu JF, Monument MJ, Grossmann A, Randall RL, Capecchi MR, Jones K (2014). Modeling alveolar soft part sarcomagenesis in the mouse: a role for lactate in the tumor microenvironment. Cancer cell, 26(6), 851-862.
  29. Kirkham M, Kalivas A, Fatema K, Luelling S, Dubansky BH, Dubansky B, Jones KB, Barrott J (2020). Underlying Ossification Phenotype in a Murine Model of Metastatic Synovial Sarcoma. International journal of molecular sciences, 21(7),
  30. Barrott JJ, Illum BE, Jin H, Zhu JF, Mosbruger T, Monument MJ, Smith-Fry K, Cable MG, Wang Y, Grossmann AH, Capecchi MR, Jones K (2015). beta-catenin stabilization enhances SS18-SSX2-driven synovial sarcomagenesis and blocks the mesenchymal to epithelial transition. Oncotarget, 6(26), 22758-66.
  31. Blank AT, Shaw S, Wakefield CJ, Zhang Y, Liu WJ, Jones KB, Randall R (2020). What factors influence patient experience in orthopedic oncology office visits?. World journal of clinical oncology, 11(3), 136-142.
  32. Blank AT, Larson BM, Shaw S, Wakefield CJ, King T, Jones KB, Randall R (2020). National Comprehensive Cancer Network guidelines compliance of a sarcoma service: A retrospective review. World journal of clinical oncology, 11(6), 389-396.
  33. Miller DT, Cortés-Ciriano I, Pillay N, Hirbe AC, Snuderl M, Bui MM, Piculell K, Al-Ibraheemi A, Dickson BC, Hart J, Jones K, Jordan JT, Kim RH, Lindsay D, Nishida Y, Ullrich NJ, Wang X, Park PJ, Flanagan A (2020). Genomics of MPNST (GeM) Consortium: Rationale and Study Design for Multi-Omic Characterization of NF1-Associated and Sporadic MPNSTs. Genes, 11(4),
  34. Jones K (2019). Dendritic Cells Drive Osteosarcomagenesis through Newly Identified Oncogene and Tumor Suppressor. Cancer discovery, 9(11), 1484-1486.
  35. Li J, Mulvihill TS, Li L, Barrott JJ, Nelson ML, Wagner L, Lock IC, Pozner A, Lambert SL, Ozenberger BB, Ward MB, Grossmann AH, Liu T, Banito A, Cairns BR, Jones K (2021). A Role for SMARCB1 in Synovial Sarcomagenesis Reveals That SS18-SSX Induces Canonical BAF Destruction. Cancer discovery, 11(10), 2620-2637.
  36. Schneider P, Giglio V, Ghanem D, Wilson D, Turcotte R, Isler M, Mottard S, Miller B, Hayden J, Doung YC, Gundle K, Randall RL, Jones K, Vélez R, Ghert (2021). Willingness of patients with sarcoma to participate in cancer surveillance research: a cross-sectional patient survey. BMJ open, 11(2), e042742.
  37. Abbott D, O'Brien S, Farnham JM, Young EL, Yap J, Jones K, Lessnick SL, Randall RL, Schiffman JD, Cannon-Albright L (2019). Increased risk for other cancers in individuals with Ewing sarcoma and their relatives. Cancer medicine, 8(18), 7924-7930.
  38. Goodwin ML, Gundavda MK, Reddy R, Deogaonkar K, Lala M, Baliarsing A, Sciubba DM, Jones KB, Agarwal (2019). Extracorporeal radiation and reimplantation: a safe and viable option for reconstruction after sacral tumor resection?. Annals of translational medicine, 7(10), 229.
  39. Tashjian RZ, Lock I, Granger EK, Wang Y, Lee Y, Chalmers PN, Jones K (2020). Gene Expression in Torn Rotator Cuff Tendons Determined by RNA Sequencing. Orthopaedic journal of sports medicine, 8(6), 2325967120927480.
  40. Kwok AC, Tatro E, Jones KB, Agarwal J (2017). Pedicled Retrograde Fibula Flap for Ankle Reconstruction after Oncologic Resection of the Distal Fibula. Plastic and reconstructive surgery. Global open, 5(2), e1232.
  41. Kim J, Light N, Subasri V, Young EL, Wegman-Ostrosky T, Barkauskas DA, Hall D, Lupo PJ, Patidar R, Maese LD, Jones K, Wang M, Tavtigian SV, Wu D, Shlien A, Telfer F, Goldenberg A, Skapek SX, Wei JS, Wen X, Catchpoole D, Hawkins DS, Schiffman JD, Khan J, Malkin D, Stewart D (2021). Pathogenic Germline Variants in Cancer Susceptibility Genes in Children and Young Adults With Rhabdomyosarcoma. JCO precision oncology, 5,
  42. Peoples AR, Oswald LB, Ose J, Daniels B, Himbert C, Hathaway CA, Gigic B, Kirchhoff AC, Lin T, Grossman D, Tward J, Varghese TK Jr, Figueiredo JC, Toriola AT, Beck A, Scaife C, Shibata D, LaStayo P, Gonzalez B, Salas K, Ashworth A, Matsen C, Christenson C, Ma DS, Colman H, Hunt JP, Jones KB, Lee CJ, Larson M, Onega T, Akerley WL, Li CI, Schneider M, Penedo FJ, Siegel EM, Tworoger SS, Ulrich C (2022). Impact of the COVID-19 pandemic on rural and urban cancer patients' experiences, health behaviors, and perceptions. The Journal of rural health, 38(4), 886-899.
  43. Guillen KP, Fujita M, Butterfield AJ, Scherer SD, Bailey MH, Chu Z, DeRose YS, Zhao L, Cortes-Sanchez E, Yang CH, Toner J, Wang G, Qiao Y, Huang X, Greenland JA, Vahrenkamp JM, Lum DH, Factor RE, Nelson EW, Matsen CB, Poretta JM, Rosenthal R, Beck AC, Buys SS, Vaklavas C, Ward JH, Jensen RL, Jones KB, Li Z, Oesterreich S, Dobrolecki LE, Pathi SS, Woo XY, Berrett KC, Wadsworth ME, Chuang JH, Lewis MT, Marth GT, Gertz J, Varley KE, Welm BE, Welm A (2022). A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology. Nature cancer, 3(2), 232-250.
  44. Brown JM, Rakoczy K, Hart J, Jones KB, Groundland J (2022). Presenting features and overall survival of chondrosarcoma of the pelvis. Cancer treatment and research communications, 30, 100510.
  45. Kraus RD, Weil CR, Wells S, Tward JD, Groundland JS, Jones KB, Cannon D (2021). Radiation Therapy in Conjunction With Surgical Stabilization of Impending or Pathologic Fractures Secondary to Metastasis: Is There a Difference Between Single and Multifraction Regimens?. Advances in radiation oncology, 7(2), 100795.
  46. Himbert C, Hathaway CA, Daniels B, Salas K, Ashworth A, Gigic B, Lin T, Viskochil R, Kirchhoff AC, Grossman D, Ose J, Tward J, Scaife C, Figueiredo JC, Toriola AT, Beck A, Shibata D, Gonzalez BD, Matsen C, Christenson C, Ma DS, Colman H, Hunt JP, Jones KB, Lee CJ, Larson M, Onega T, Akerley WL, Li CI, Schneider M, Penedo FJ, Siegel EM, Tworoger SS, Ulrich CM, Peoples A (2022). Factors associated with changes in exercise behaviors during the COVID-19 pandemic. Cancer causes & control, 33(7), 939-950.
  47. Pires G, Moss WD, Luo J, Zhang R, Jones KB, Kwok AC, Agarwal J (2022). Free Vascularized Fibula Salvage of Failed CPH in Pediatric Sarcoma Patients. Sarcoma, 2022, 6240293.
  48. Brashears CB, Prudner BC, Rathore R, Caldwell KE, Dehner CA, Buchanan JL, Lange SES, Poulin N, Sehn JK, Roszik J, Spitzer D, Jones KB, O'Keefe RJ, Nielsen TO, Taylor EB, Held JM, Hawkins W, Van Tine B (2022). Malic Enzyme 1 Absence in Synovial Sarcoma Shifts Antioxidant System Dependence and Increases Sensitivity to Ferroptosis Induction with ACXT3102. Clinical cancer research, 28, 3573-3589.
  49. Bovée JV, Webster F, Amary F, Baumhoer D, Bloem JLH, Bridge J, Cates JM, de Alava E, Dei Tos AP, Jones KB, Mahar A, Nielsen GP, Righi A, Wagner AJ, Yoshida A, Fletcher C (2022). Datasets for the reporting of primary tumour in bone: recommendations from the International Collaboration on Cancer Reporting (ICCR). Histopathology, 82(4), 531-540.
  50. Brown JM, Rakoczy K, Tokson JH, Jones KB, Groundland J (2022). Ewing sarcoma of the pelvis: Clinical features and overall survival(). Cancer treatment and research communications, 33, 100634.
  51. Wang XQ, Brown JM, Lorimer S, Jones KB, Groundland J (2023). Thermal necrosis in orthopedic bone tumors: experimental research. Annals of medicine and surgery (2012), 85(9), 4372-4377.
  52. Aßmann ES, Ose J, Hathaway CA, Oswald LB, Hardikar S, Himbert C, Chellam V, Lin T, Daniels B, Kirchhoff AC, Gigic B, Grossman D, Tward J, Varghese TK Jr, Shibata D, Figueiredo JC, Toriola AT, Beck A, Scaife C, Barnes CA, Matsen C, Ma DS, Colman H, Hunt JP, Jones KB, Lee CJ, Larson M, Onega T, Akerley WL, Li CI, Grady WM, Schneider M, Dinkel A, Islam JY, Gonzalez BD, Otto AK, Penedo FJ, Siegel EM, Tworoger SS, Ulrich CM, Peoples A (2024). Risk factors and health behaviors associated with loneliness among cancer survivors during the COVID-19 pandemic. Journal of behavioral medicine, 47(3), 405-421.
  53. Prakasam G, Mishra A, Christie A, Miyata J, Carrillo D, Tcheuyap VT, Ye H, Do QN, Wang Y, Reig Torras O, Butti R, Zhong H, Gagan J, Jones KB, Carroll TJ, Modrusan Z, Durinck S, Requena-Komuro MC, Williams NS, Pedrosa I, Wang T, Rakheja D, Kapur P, Brugarolas (2024). Comparative genomics incorporating translocation renal cell carcinoma mouse model reveals molecular mechanisms of tumorigenesis. The Journal of clinical investigation,
  54. Pozner A, Li L, Verma SP, Wang S, Barrott JJ, Nelson ML, Yu JSE, Negri GL, Colborne S, Hughes CS, Zhu JF, Lambert SL, Carroll LS, Smith-Fry K, Stewart MG, Kannan S, Jensen B, John CM, Sikdar S, Liu H, Dang NH, Bourdage J, Li J, Vahrenkamp JM, Mortenson KL, Groundland JS, Wustrack R, Senger DL, Zemp FJ, Mahoney DJ, Gertz J, Zhang X, Lazar AJ, Hirst M, Morin GB, Nielsen TO, Shen PS, Jones K (2024). ASPSCR1-TFE3 reprograms transcription by organizing enhancer loops around hexameric VCP/p97. Nature communications, 15(1), 1165.
  55. Brown JM, Patel R, Smith-Fry K, Ward M, Oliver T, Jones K (2024). Genetically engineered mouse model of pleomorphic liposarcoma: Immunophenotyping and histologic characterization. Neoplasia (New York, N.Y.), 48, 100956.
  56. Ozenberger BB, Li L, Wilson ER, Lazar AJ, Barrott JJ, Jones K (2023). EWSR1::ATF1 Orchestrates the Clear Cell Sarcoma Transcriptome in Human Tumors and a Mouse Genetic Model. Cancers, 15(24),
  57. Westlake B, Brown J, Hart J, Skiby C, Jones K, Groundland (2024). Exploring the Diagnostic Dilemma of Indeterminate Pulmonary Nodules in Patients with Primary Sarcoma of Bone. Sarcoma, 2024, 9926675.
  58. Hansen SA, Hart ML, Busi S, Parker T, Goerndt A, Jones K, Amos-Landgraf JM, Bryda E (2016). Fischer-344 Tp53-knockout rats exhibit a high rate of bone and brain neoplasia with frequent metastasis. Disease models & mechanisms, 9(10), 1139-1146.
  59. Floros KV, Fairchild CK Jr, Li J, Zhang K, Roberts JL, Kurupi R, Hu B, Kraskauskiene V, Hosseini N, Shen S, Inge MM, Smith-Fry K, Li L, Sotiriou A, Dalton KM, Jose A, Abdelfadiel EI, Xing Y, Hill RD, Slaughter JM, Shende M, Lorenz MR, Hinojosa MR, Belvin BR, Lai Z, Boikos SA, Stamatouli AM, Lewis JP, Manjili MH, Valerie K, Li R, Banito A, Poklepovic A, Koblinski JE, Siggers T, Dozmorov MG, Jones KB, Radhakrishnan SK, Faber A (2024). Targeting of SUMOylation leads to cBAF complex stabilization and disruption of the SS18::SSX transcriptome in Synovial Sarcoma. Research square,
  60. Fatema K, Wang Y, Pavek A, Larson Z, Nartker C, Plyler S, Jeppesen A, Mehling B, Capecchi MR, Jones KB, Barrott J (2024). Arid1a Loss Enhances Disease Progression in a Murine Model of Osteosarcoma. Cancers, 16(15),
  61. Hofvander J, Qiu A, Lee K, Bilenky M, Carles A, Cao Q, Moksa M, Steif J, Su E, Sotiriou A, Goytain A, Hill LA, Singer S, Andrulis IL, Wunder JS, Mertens F, Banito A, Jones KB, Underhill TM, Nielsen TO, Hirst (2024). Synovial Sarcoma Chromatin Dynamics Reveal a Continuum in SS18:SSX Reprograming. bioRxiv,
  62. Groundland J, Tokson JH, Hakim A, Cizik A, Blank A, Lerman D, Jones K, Lor Randall (2024). Length of Time to Clinical Improvement After Orthopedic Oncology Surgery in Patients With Metastatic Cancer: A Multi-Institution Patient-Reported Outcome Study. Journal of surgical oncology,
  63. Hasegawa N, Benabdallah NS, Smith-Fry K, Li L, McCollum S, Li J, Jones CA, Wagner L, Dalal V, Golde V, Pejkovska A, Carroll L, Haldar M, Pollack SM, Lowe SW, Nielsen TO, Banito A, Jones K (2025). DNA demethylating agents suppress preclinical models of synovial sarcoma. The Journal of clinical investigation, 135(13),
  64. Imle R, Blösel D, Kommoss FKF, Placke S, Stutheit-Zhao E, Blume C, Lupar D, Schmitt L, Winter C, Wagner L, von Eicke M, Walzer H, Förderer J, Laier S, Hertwig M, Peterziel H, Oehme I, Scheuerman S, Seitz CM, Geyer FH, Cidre-Aranaz F, Grünewald TGP, Vokuhl C, Chudasama P, Scholl C, Schmidt C, Günther P, Sill M, Jones KB, Pfister SM, Autry RJ, Banito (2025). Somatic gene delivery faithfully recapitulates a molecular spectrum of high-risk sarcomas. Nature communications, 16(1), 5283.

Review

  1. Stacchiotti S, Maria Frezza A, Demetri GD, Blay JY, Bajpai J, Baldi GG, Baldini EH, Benjamin RS, Bonvalot S, Bovée JVMG, Callegaro D, Casali PG, D'Angelo SP, Davis EJ, Dei Tos AP, Demicco EG, Desai J, Dileo P, Eriksson M, Gelderblom H, George S, Gladdy RA, Gounder MM, Gupta AA, Haas R, Hayes A, Hohenberger P, Jones KB, Jones RL, Kasper B, Kawai A, Kirsch DG, Kleinerman ES, Le Cesne A, Maestro R, Martin Broto J, Maki RG, Miah AB, Palmerini E, Patel SR, Raut CP, Razak ARA, Reed DR, Rutkowski P, Sanfilippo RG, Sbaraglia M, Schaefer IM, Strauss DC, Strauss SJ, Tap WD, Thomas DM, Trama A, Trent JC, van der Graaf WTA, van Houdt WJ, von Mehren M, Wilky BA, Fletcher CDM, Gronchi A, Miceli R, Wagner A (2022). Retrospective observational studies in ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society (CTOS) community of experts on the minimum requirements for the evaluation of activity of systemic treatments. Cancer treatment reviews, 110, 102455.
  2. Burns J, Brown JM, Jones KB, Huang P (2022). The Cancer Genome Atlas: Impact and Future Directions in Sarcoma. Surgical oncology clinics of North America, 31(3), 559-568.
  3. Wang AX, Jones KB, Nielsen T (2025). Molecular and epigenetic oncogenesis in synovial sarcoma: implications for cancer biology, diagnosis and treatment. Oncogene, 44(38), 3527-3536.
  4. Peck A, Dadi A, Yavarow Z, Alfano LN, Anderson D, Arkin MR, Chou TF, D'Ambrosio ES, Diaz-Manera J, Dudley JP, Elder AG, Ghoshal N, Hart CE, Hart MM, Huryn DM, Johnson AE, Jones KB, Kimonis V, Kiskinis E, Lee EB, Lloyd TE, Mapstone M, Martin A, Meyer H, Mozaffar T, Onyike CU, Pfeffer G, Pindon A, Raman M, Richard I, Rubinsztein DC, Schiava M, Schütz AK, Shen PS, Southworth DR, Staffaroni AM, Taralio-Gravovac M, Weihl CC, Yao Q, Ye Y, Peck (2025). 2024 VCP International Conference: Exploring multi-disciplinary approaches from basic science of valosin containing protein, an AAA+ ATPase protein, to the therapeutic advancement for VCP-associated multisystem proteinopathy. Neurobiology of disease, 207, 106861.

Case Report

  1. Serpico R, Brown J, Blank A, Jones K, Randall RL, Groundland (2021). Metastasis of Osteosarcoma to the Abdomen: A Report of Two Cases and a Review of the Literature. Case reports in oncology, 14(1), 647-658.
  2. Abbasi AM, Hosein RC, Willis RN Jr, Lelkes VM, Jones KB, Agarwal J (2021). Modified Rotationplasty as a Composite Free Flap for Femur and Thigh Reconstruction. World journal of plastic surgery, 10(2), 115-119.
  3. Blank AT, Wakefield C, Khalighi M, Jones KB, Randall R (2019). Epithelioid Osteoblastoma of the Proximal Femur in a 19-Year-Old Female: A Case Report and Review of Literature. Journal of orthopaedic case reports, 9(5), 74-77.

Other

  1. Himbert C, Hathaway CA, Daniels B, Salas K, Ashworth A, Gigic B, Lin T, Viskochil R, Kirchhoff AC, Grossman D, Ose J, Tward J, Scaife C, Figueiredo JC, Toriola AT, Beck A, Shibata D, Gonzalez BD, Matsen C, Christenson C, Ma DS, Colman H, Hunt JP, Jones KB, Lee CJ, Larson M, Onega T, Akerley WL, Li CI, Schneider M, Penedo FJ, Siegel EM, Tworoger SS, Ulrich CM, Peoples A (2021). Impact of the COVID-19 pandemic on exercise habits among cancer patients.

Research Lab

Lab link

News & Podcasts

Huntsman Cancer Institute News